Research

Packages

Life of the unit

Next seminars

Last publications

Updated

Les travaux en cours

2020

Articles dans une revue internationale

• 1. Caillet P, Rousselet M, Gérardin M, Jolliet P, Victorri-Vigneau C (2020) Prevalence of zolpidem use in France halved after secure prescription pads implementation in 2017: a SNDS database nested cohort study.. Plos One, 15(2): .

Publications soumise ou en révision

• 1. (Soumis) Chatton A, Le Borgne F, Leyrat C, Foucher Y (2020) G-computation and inverse probability weighting for time-to-event outcomes: a comparative study.

2019

Articles dans une revue internationale

• 1. Gorwood P, Duriez P, Lengvenyte A, Guillaume S, Criquillion S, FFAB network (2019) Clinical insight in anorexia nervosa: Associated and predictive factors. Psychiatry Research(127): 112561.


• 2. Karsenti D, Tharsis G, Zeitoun J, Denis P, Perrot B, Coelho J, Bellaiche G, Charbit L, Hakoune J, Doumet S, Sion-Rohart E, Cavicchi M, Zago J (2019) Comparison of 20-gauge Procore® and 22-gauge Acquire® needles for EUS-FNB of solid pancreatic masses: an observational study. Scandinavian Journal of Gastroenterology, 8: 1-7.


• 3. Montassier E, Javaudin F, Moustafa F, Nandjou D, Maignan M, Hardouin JB, Annoot C, Ogielska M, Orer PL, Schotté T, Bouget J, Agha Babaei S, Raynal PA, Eche A, Duc AT, Cojocaru RA, Benaouicha N, Potel G, Batard E, Talan DA. (2019) Guideline-Based Clinical Assessment Versus Procalcitonin-Guided Antibiotic Use in Pneumonia: A Pragmatic Randomized Trial. Ann Emerg Med(19): 30147-7.


• 4. Victorri-Vigneau C, Verstuyft C, Bouquié R, Laforgue E, Hardouin JB, Leboucher J, Le Geay B, Dano C, Challet G, Grall-Bronnec M (2019) Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study. British Journal of Clinical Pharmacology, 85(7): 1538-1543.

Publications soumise ou en révision

• 1. (Soumis) Vanier A, Sébille V, Blanchin M, Hardouin JB (2019) Soumis, The Minimal Perceived Change : a formal model of the Responder Definition according to the patient’s meaning of change for Patient-Reported Outcomes data analysis and interpretation.


• 2. (Soumis) Malloggi L, Le Glatin C, Leclère B, Moret L (2019) Patient involvement in healthcare workers’ practices: how does it operate? A mixed-methods study in a French university hospital.


• 3. (Soumis) Cartron E, Januel JM, Leclère B, Moret L (2019) The complexity of shared decision-making: a mixed-method systematic review of factors according to patient, healthcare professionals and context.


• 4. (Soumis) Woaye Hune P, Hardouin JB, Lehur PA, Meurette A, Vanier A (2019) En review, Practical issues encountered while determining Minimal Clinically Important Difference in Patient-Reported Outcomes..

2018

2017

Publications soumise ou en révision

• 1. (Soumis) Blanchin M, Guilleux A, Hardouin JB, Sébille V (2017) Searching for an optimal SEM-based method to assess response shift at item level: a simulation study.

2016

Publications soumise ou en révision

• 1. (Soumis) Blanchin M, Hardouin JB, Le Neel T, Kubis G, Sébille V (2016) CTT and Rasch-based approaches for joint analysis of group and time effects of longitudinal Patient Reported Outcomes: impact of dropout mechanisms..


• 2. (Soumis) Bruneau M, Hardouin JB, Sauvaget A, Vénisse JL, Grall-Bronnec M (2016) Gambling trajectory: impact of gender among a population of problem gamblers seeking treatment.

2015

2014

0

Articles dans une revue internationale

• 1. Dahyot-Fizelier C, Frasca D, Lasocki S, Asehnoune K, Balayn D, Guerin AL, Perrigault PF, Geeraerts T, Seguin P, Rozec B, Elaroussi D, Cottenceau V, Guyonnaud C, Mimoz O; PROPHY-VAP Study group, ATLANREA group. Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial.. , 8(10): .


• 2. Fidalgo M, Prudhomme T, Allio A, Grall-Bronnec M, Bulteau S, Jolliet P, Victorri-Vigneau C Nitrous oxide: What do we know about its use disorder potential? Results of the French Monitoring Centre for Addiction network survey and literature review. Subst Abus, 40(1): 33-42.